Fortis Healthcare Sees Sharp Open Interest Surge Amid Bearish Momentum

Open Interest and Volume Dynamics

On 24 Sep 2026, Fortis Healthcare’s open interest (OI) in derivatives rose sharply to 26,168 contracts from 21,005 the previous day, marking an increase of 5,163 contracts or 24.58%. This substantial rise in OI indicates that new positions are being established rather than existing ones being squared off. The volume for the day stood at 12,668 contracts, reflecting active trading interest but still below the OI increase, which often points to fresh bets being placed rather than mere position adjustments.

The futures value associated with Fortis Healthcare’s derivatives reached ₹65,332.45 lakhs, while the options segment exhibited a massive notional value of approximately ₹2,276.13 crores. The combined total derivatives value stood at ₹65,493.88 lakhs, underscoring the sizeable capital flow in the stock’s derivatives market.

Price Performance and Technical Context

Despite the surge in derivatives activity, Fortis Healthcare’s underlying stock price has been under pressure. The stock closed at ₹886, down 1.12% on the day, slightly underperforming the hospital sector’s 0.85% decline but outperforming the broader Sensex’s 1.52% fall. Notably, the stock has recorded losses over the past two consecutive sessions, with a cumulative decline of 1.38% during this period.

Technical indicators reveal that Fortis Healthcare is trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a bearish trend. The narrow trading range of just ₹0.45 on the day further highlights subdued price volatility despite the heightened derivatives activity.

Investor Participation and Liquidity Considerations

Investor participation appears to be waning, with delivery volumes on 23 Sep falling by 20.02% to 6.19 lakh shares compared to the five-day average. This decline in delivery volume suggests reduced conviction among long-term investors, possibly reflecting caution amid the stock’s recent weakness.

Nevertheless, liquidity remains adequate for sizeable trades, with the stock’s average traded value supporting transactions up to ₹2.23 crores based on 2% of the five-day average traded value. This liquidity profile ensures that institutional and retail participants can execute meaningful trades without excessive market impact.

Market Positioning and Potential Directional Bets

The sharp increase in open interest amid a falling stock price suggests that market participants may be positioning for further downside or hedging existing exposures. The divergence between rising OI and declining price often indicates fresh short positions or protective put buying in the options market.

Fortis Healthcare’s Mojo Score currently stands at 44.0, with a Mojo Grade of Sell, downgraded from Hold on 15 Sep 2026. This downgrade reflects deteriorating fundamentals or technical weakness, which may be influencing traders’ bearish sentiment. The mid-cap hospital sector stock’s market capitalisation is ₹66,810.02 crores, placing it in a segment where volatility and speculative activity can be pronounced.

Options data, with an enormous notional value exceeding ₹2,276 crores, indicates that sophisticated investors are actively using derivatives to express views or manage risk. The futures market’s sizeable ₹653.32 crore value further confirms strong institutional interest.

Given the stock’s trading below all major moving averages and falling investor participation, the derivatives surge could be interpreted as a directional bet favouring continued weakness. However, the narrow price range and relatively stable volume suggest that some participants may also be employing complex strategies such as spreads or collars to hedge positions.

Sector and Benchmark Comparison

Fortis Healthcare’s performance today was broadly in line with the hospital sector’s modest decline of 0.85%, though it marginally underperformed. The Sensex’s sharper fall of 1.52% indicates that the stock has shown relative resilience compared to the broader market. This relative stability, despite negative technical signals, may attract contrarian traders looking for a potential reversal or consolidation phase.

However, the overall negative momentum and the recent downgrade in Mojo Grade caution investors to remain vigilant. The stock’s falling delivery volumes and persistent trading below key moving averages reinforce the need for careful risk management.

Outlook and Investor Takeaways

Investors should approach Fortis Healthcare with caution given the current technical and derivatives market signals. The significant open interest increase amid falling prices and declining delivery volumes points to a market consensus leaning towards bearishness or hedging activity. The downgrade to a Sell grade by MarketsMOJO further emphasises the need for prudence.

However, the stock’s relative outperformance against the Sensex and the narrow trading range may indicate a potential base formation or consolidation ahead. Traders with a higher risk appetite might consider monitoring option open interest changes closely for signs of a shift in sentiment, such as a pick-up in call option activity or a reduction in put open interest.

Given the mid-cap status and sector dynamics, Fortis Healthcare remains a stock where volatility can present both risks and opportunities. Investors should weigh the fundamental outlook alongside technical and derivatives market data before making allocation decisions.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today